Back to search

Article

Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria

2023-09-29

Abstract excerpt

<h4>Background: </h4> Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are the two most common subtypes within rare genetic photodermatoses, which can lead to incapacitating pain episodes. <h4>Methods:</h4> We reviewed previous and current treatment options for EPP/XLP, notably with a focus on metabolism, pharmacokinetics, mechanism of action, key clinical trial results, and limitations of Der...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4b60ee8-dfb0-53e5-be5c-c5126d854fdb
DOI
10.20944/preprints202309.2077.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked ProtoporphyriaDOI 10.20944/preprints202309.2077.v1
Select a neighboring publication to make it the new centre.